Lisignoli V - Search Results

1

DES implantation in saphenous vein and left internal mammary grafts.

Presbitero P, Zavalloni D, Pagnotta P, Belli G, Rossi ML, Gasparini GL, Lisignoli V. Presbitero P, et al. Among authors: lisignoli v. Minerva Cardioangiol. 2008 Feb;56(1):79-87. Minerva Cardioangiol. 2008. PMID: 18432171 Review.

2

Endovascular intervention in the treatment of congenital heart disease in adults.

Presbitero P, Lisignoli V, Zavalloni D, Rossi ML, Gasparini GL, Belli G, Pagnotta P. Presbitero P, et al. Among authors: lisignoli v. Minerva Cardioangiol. 2007 Oct;55(5):669-79. Minerva Cardioangiol. 2007. PMID: 17912170 Review.

3

Anatomical patterns of patent foramen ovale (PFO): do they matter for percutaneous closure?

Presbitero P, Lanzone AM, Albiero R, Lisignoli V, Zavalloni Parenti D, Gasparini GL, Lodigiani C, Barbaro C, Fappani A, Barberis G, Rossi ML, Pagnotta P. Presbitero P, et al. Among authors: lisignoli v. Minerva Cardioangiol. 2009 Jun;57(3):275-84. Minerva Cardioangiol. 2009. PMID: 19513008

4

Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery.

Zavalloni D, Rossi ML, Scatturin M, Morenghi E, Soregaroli D, Municino A, Gasparini GL, Lisignoli V, Barbaro C, Presbitero P. Zavalloni D, et al. Among authors: lisignoli v. Coron Artery Dis. 2007 Sep;18(6):495-500. doi: 10.1097/MCA.0b013e3282cf4ba9. Coron Artery Dis. 2007. PMID: 17700223 Clinical Trial.

5

"Gender paradox" in outcome after percutaneous coronary intervention with paclitaxel eluting stents.

Presbitero P, Belli G, Zavalloni D, Rossi ML, Lisignoli V, Barberis G, Gasparini GL, Scatturin M, Morenghi E, Pagnotta P. Presbitero P, et al. Among authors: lisignoli v. EuroIntervention. 2008 Nov;4(3):345-50. doi: 10.4244/eijv4i3a62. EuroIntervention. 2008. PMID: 19110808

6

Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation.

Rossi ML, Zavalloni D, Scatturin M, Gasparini GL, Lisignoli V, Presbitero P. Rossi ML, et al. Among authors: lisignoli v. Expert Opin Pharmacother. 2007 Sep;8(13):2017-24. doi: 10.1517/14656566.8.13.2017. Expert Opin Pharmacother. 2007. PMID: 17714056

7

Inflammatory substrate with eosinophils may be present in bare-metal stent thrombosis.

Zavalloni D, Bossi P, Rossi ML, Gasparini GL, Lisignoli V, Presbitero P. Zavalloni D, et al. Among authors: lisignoli v. J Cardiovasc Med (Hagerstown). 2009 Dec;10(12):942-3. doi: 10.2459/JCM.0b013e32832f3f8e. J Cardiovasc Med (Hagerstown). 2009. PMID: 19593162

8

Closure of patent foramen ovale: when and how?

Lisignoli V, Lanzone AM, Zavalloni D, Pagnotta P, Presbitero P. Lisignoli V, et al. Curr Vasc Pharmacol. 2007 Oct;5(4):322-7. doi: 10.2174/157016107782023370. Curr Vasc Pharmacol. 2007. PMID: 17979798

9

Platypnoea-orthodeoxia syndrome secondary to patent foramen ovale (PFO): a challenging subset for PFO percutaneous closure.

Zavalloni D, Lisignoli V, Barbaro C, Mennuni M, Tosi P, Marcheselli S, Presbitero P. Zavalloni D, et al. Among authors: lisignoli v. Heart Lung Circ. 2013 Aug;22(8):642-6. doi: 10.1016/j.hlc.2013.01.007. Epub 2013 Feb 24. Heart Lung Circ. 2013. PMID: 23497825

10

A case of platypnea-orthodeoxia syndrome caused by the interaction between the presence of corrected transposition of the great arteries and patent foramen ovale.

Gasparini G, Rossi M, Zavalloni D, Belli G, Pagnotta P, Lisignoli V, Barbaro C, Lanzone A, Presbitero P. Gasparini G, et al. Among authors: lisignoli v. Int J Cardiol. 2010 Jan 7;138(1):e1-3. doi: 10.1016/j.ijcard.2008.06.018. Epub 2008 Aug 15. Int J Cardiol. 2010. PMID: 18706706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters